These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36301030)

  • 1. Downregulated formyl peptide receptor 2 expression in the epileptogenic foci of patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Huang K; Wang Z; He Z; Li Y; Li S; Shen K; Zhu G; Liu Z; Lv S; Zhang C; Yang H; Yang X; Liu S
    Immun Inflamm Dis; 2022 Nov; 10(11):e706. PubMed ID: 36301030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulated GPR30 expression in the epileptogenic foci of female patients with focal cortical dysplasia type IIb and tuberous sclerosis complex is correlated with
    Wang Z; Huang K; Yang X; Shen K; Yang L; Ruan R; Shi X; Wang M; Zhu G; Yang M; Zhang C; Lv S; Yang H; Fan X; Liu S
    Brain Pathol; 2021 Mar; 31(2):346-364. PubMed ID: 33314369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q
    Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb.
    Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H
    J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of leukocyte immunoglobulin-like receptor B2 signaling pathway in cortical lesions of pediatric patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Yue J; Zhang C; Shi X; Wei Y; Liu L; Liu S; Yang H
    Brain Dev; 2019 Nov; 41(10):829-838. PubMed ID: 31495513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H
    Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of CD47 and CD200 in patients with focal cortical dysplasia type IIb and tuberous sclerosis complex.
    Sun FJ; Zhang CQ; Chen X; Wei YJ; Li S; Liu SY; Zang ZL; He JJ; Guo W; Yang H
    J Neuroinflammation; 2016 Apr; 13(1):85. PubMed ID: 27095555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
    Arena A; Zimmer TS; van Scheppingen J; Korotkov A; Anink JJ; Mühlebner A; Jansen FE; van Hecke W; Spliet WG; van Rijen PC; Vezzani A; Baayen JC; Idema S; Iyer AM; Perluigi M; Mills JD; van Vliet EA; Aronica E
    Brain Pathol; 2019 May; 29(3):351-365. PubMed ID: 30303592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of bone morphogenetic protein-4 in the cortical lesions of focal cortical dysplasia IIb and the tuberous sclerosis complex.
    Guo W; Zhang CQ; Shu HF; Yang MH; Yin Q; Yang H
    J Mol Neurosci; 2013 May; 50(1):7-13. PubMed ID: 22752548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered expression of the Plexin-B2 system in tuberous sclerosis complex and focal cortical dysplasia IIb lesions.
    Dai L; Huang J; Shen KF; Yang XL; Zhu G; Zhang L; Wang ZK; Liu SY; Liao X; Xu SL; Yang H; Li XY; Zhang CQ
    Histol Histopathol; 2024 Sep; 39(9):1179-1195. PubMed ID: 38293776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM; Sun H; Kosaras B; Joseph A; Folkerth RD; Poduri A; Madsen JR; Black PM; Jensen FE
    Ann Neurol; 2012 Apr; 71(4):539-51. PubMed ID: 22447678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
    Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E
    Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and cellular distribution of FGF13 in cortical tubers of the tuberous sclerosis complex.
    Wu K; Yue J; Shen K; He J; Zhu G; Liu S; Yang H; Zhang CQ
    Neurosci Lett; 2021 Apr; 749():135714. PubMed ID: 33582188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for mTOR pathway activation in a spectrum of epilepsy-associated pathologies.
    Liu J; Reeves C; Michalak Z; Coppola A; Diehl B; Sisodiya SM; Thom M
    Acta Neuropathol Commun; 2014 Jul; 2():71. PubMed ID: 25005575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of autophagy-related proteins in malformations of cortical development].
    Chen S; Piao Y; Fu Y; Li Z; Liu C; Lu D
    Zhonghua Bing Li Xue Za Zhi; 2015 May; 44(5):305-9. PubMed ID: 26178210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the pathogenic transcription factor SPI1/PU.1 in tuberous sclerosis complex and focal cortical dysplasia by oxidative stress.
    Zimmer TS; Korotkov A; Zwakenberg S; Jansen FE; Zwartkruis FJT; Rensing NR; Wong M; Mühlebner A; van Vliet EA; Aronica E; Mills JD
    Brain Pathol; 2021 Sep; 31(5):e12949. PubMed ID: 33786950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced GABAergic network and receptor function in pediatric cortical dysplasia Type IIB compared with Tuberous Sclerosis Complex.
    Cepeda C; André VM; Hauptman JS; Yamazaki I; Huynh MN; Chang JW; Chen JY; Fisher RS; Vinters HV; Levine MS; Mathern GW
    Neurobiol Dis; 2012 Jan; 45(1):310-21. PubMed ID: 21889982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies.
    Martinian L; Boer K; Middeldorp J; Hol EM; Sisodiya SM; Squier W; Aronica E; Thom M
    Neuropathol Appl Neurobiol; 2009 Aug; 35(4):394-405. PubMed ID: 19508443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical characterization of the out-of frame splice variants GFAP Delta164/Deltaexon 6 in focal lesions associated with chronic epilepsy.
    Boer K; Middeldorp J; Spliet WG; Razavi F; van Rijen PC; Baayen JC; Hol EM; Aronica E
    Epilepsy Res; 2010 Jun; 90(1-2):99-109. PubMed ID: 20430588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.